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Abstract
The adaptability of the central nervous system has been revealed in several model systems. Of particular
interest to central nervous system-injured individuals is the ability for neural components to be modified
for regain of function. In both types of neurotrauma, traumatic brain injury and spinal cord injury, the
primary parasympathetic control to the gastrointestinal tract, the vagus nerve, remains anatomically
intact. However, individuals with traumatic brain injury or spinal cord injury are highly susceptible to
gastrointestinal dysfunctions. Such gastrointestinal dysfunctions attribute to higher morbidity and
mortality following traumatic brain injury and spinal cord injury. While the vagal efferent output remains
capable of eliciting motor responses following injury, evidence suggests impairment of the vagal
afferents. Since sensory input drives motor output, this review will discuss the normal and altered
anatomy and physiology of the gastrointestinal vagal afferents to better understand the contributions of
vagal afferent plasticity following neurotrauma.
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The adaptability of the central nervous system has been revealed in several model systems.
Of particular interest to central nervous system-injured individuals is the ability for
neural components to be modified for regain of function. In both types of neurotrauma,
traumatic brain injury and spinal cord injury, the primary parasympathetic control to the
gastrointestinal tract, the vagus nerve, remains anatomically intact. However, individuals
with traumatic brain injury or spinal cord injury are highly susceptible to gastrointestinal
dysfunctions. Such gastrointestinal dysfunctions attribute to higher morbidity and
mortality following traumatic brain injury and spinal cord injury. While the vagal efferent
output remains capable of eliciting motor responses following injury, evidence suggests
impairment of the vagal afferents. Since sensory input drives motor output, this review
will discuss the normal and altered anatomy and physiology of the gastrointestinal vagal
afferents to better understand the contributions of vagal afferent plasticity following
neurotrauma.
Key Words: gastrointestinal functions; microbiome; neurotrauma; nodose ganglia; sensory
neuropathy; spinal cord injury; traumatic brain injury; vagal afferents; visceral reflexes

Introduction
Central nervous system (CNS) trauma, or neurotrauma, is a
result of sudden insult or mechanical force to the head or
spine (Chang and Badjatia, 2014; Wang et al., 2018; Yates et al.,
2019). The types of neurotrauma vary but include concussion,
skull fractures, traumatic brain injury (TBI), spinal column
fractures, and spinal cord injuries (SCI; Icahn, 2020). The World
Health Organization (WHO) has recognized neurotrauma as a
“critical public health problem” which leads to significant losses
to the injured individual, the individual’s family, and the entire
community as a result of lifelong disabilities or death (WHO,
2020). One comorbidity that is often overlooked following
neurotrauma is dysregulation of the gastrointestinal (GI) organs
associated with nutrient homeostasis. The function of the GI
tract in health and disease is well-studied in the neurally-intact
organism. Due to increased survivability after neurotrauma,
it is imperative to understand the long-term consequences
of neural injury and plasticity towards repair and regain of
function of this vital organ system.
In the USA, there are approximately 1.7–2.0 million incidents
of TBI annually (Huang, 2013; Wang et al., 2018), and
there are about 5.3 million Americans currently living with
permanent TBI-related comorbidities (Wang et al., 2018).
These comorbidities include derangements in physical,
emotional, and behavioral functions, neurocognitive
disabilities (Langlois et al., 2006; McCrory et al., 2009;
Daneshvar et al., 2011) and a vegetative state (McKee and
Daneshvar, 2015). While there are both intracranial and
extracranial complications post-TBI, the extracranial deficits
are systemic and may involve any organ system. The most

commonly affected organ systems include the vagallyinnervated respiratory, cardiovascular, and GI systems. GI
dysfunctions following TBI (Pilitsis and Rengachary, 2001; Hang
et al., 2003; Zygun et al., 2005; Kemp et al., 2008; Masel and
DeWitt, 2010; Olsen et al., 2013; Katzenberger et al., 2015;
Vance et al., 2015) affect greater than 50% (Qi et al., 2011) of
TBI individuals and include impaired swallowing (Mackay et
al., 1999; Morgan and Mackay, 1999), decreased pharyngeal
sensation, prolonged transit, (Morgan and Mackay, 1999),
GI bleeding (Kamada et al., 1977; Brown et al., 1989; Lu et
al., 1997), gastric reflux (Saxe et al., 1994; Kao et al., 1998),
delayed gastric emptying (Qi et al., 2011), decreased tone in
the lower esophageal sphincter (Kamada et al., 1977; Brown
et al., 1989; Philip, 1992; Saxe et al., 1994; Pedoto et al., 1995;
Lu et al., 1997; Kao et al., 1998; Pilitsis and Rengachary, 2001),
gastroparesis (Brown et al., 1989; Jackson and Davidoff, 1989;
Pilitsis and Rengachary, 2001), decreased intestinal peristalsis
(Philip, 1992; Pedoto et al., 1995), mucosal damage with
increased gut permeability (Bansal et al., 2009; Katzenberger
et al., 2015), and altered GI motility (Jackson and Davidoff,
1989). Of the post-TBI GI complications, the most common
comorbidity is gastritis with a reported incidence of 74–100%
(Kamada et al., 1977; Brown et al., 1989). Lastly, 68% of TBI
individuals suffer from chronic malnourishment (Horneman
et al., 2005) which further exacerbates system-wide deficits
from lack of nutrients. GI dysfunctions contribute to postTBI morbidity and mortality (Qi et al., 2011); yet, the exact
mechanisms for GI dysfunctions following TBI remain unclear.
The devastating losses in motor, GI, bladder, and sexual
function are continually rated as the top regain of function
priorities for SCI individuals (Anderson, 2004; Simpson et
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al., 2012; van Middendorp et al., 2016). Bladder and GI
dysfunctions have been described as the “most debilitating”
of these burdens because they not only impact the health of
SCI individuals, but greatly limit their relationships and social
interactions, further diminishing their quality of life (Simpson
et al., 2012; Braaf et al., 2017). Specifically, reports indicate
that high thoracic or cervical spinal trauma most often
lead to delayed gastric emptying, early satiety, dysphagia,
constipation, incontinence, nausea, bloating, and abdominal
pain (Wolf and Meiners, 2003; Park and Camilleri, 2006; Fynne
et al., 2012).
Gastric functions and other upper GI functions are dominated
by and dependent on extrinsic parasympathetic nervous
system circuits for regulation (Browning and Travagli,
2014; Travagli and Anselmi, 2016). The vagus nerve (VN)
contains the visceral afferent and efferent fibers essential for
parasympathetic nervous system-mediated reflexes. In both
TBI and SCI, the VN remains anatomically intact following
injury; however, evidence suggests that the parasympathetic
nervous system and the enteric nervous system (ENS)
within the gut no longer cooperatively coordinate GI
functions suggesting a disruption in the vago-vagal reflexes.
The normal anatomy and physiology of the VN has been
extensively discussed by others (Lal et al., 2001; Browning
and Mendelowitz, 2003; Undem et al., 2004; Blackshaw et
al., 2007; Wang and Powley, 2007; Browning and Travagli,
2011; Potenzieri et al., 2012; Holmes et al., 2013; Bonaz et
al., 2016; Grabauskas and Owyang, 2017; Breit et al., 2018;
Driessen, 2019; Fülling et al., 2019). For our purposes, the
following brief summary of VN anatomy and physiology is
provided to give a frame of reference for our discussion
of vagal neuroplasticity following CNS trauma. This review
highlights the role of the VN in GI sensory signaling and the
neuroplasticity that occurs following TBI and SCI.
The PubMed database was used between November 2019
and January 2020, using the search terms: traumatic brain
injury/TBI, spinal cord injury/SCI, stroke, nodose ganglia, vagal
afferents, vagus nerve, microbiome, and various combinations
of these search terms.

Normal Anatomy and Physiology of the Vagus
Nerve
Gastrointestinal vago-vagal reflex
The autonomic regulation of the GI tract in the context of
SCI has recently been reviewed (Holmes and Blanke, 2019).
Briefly, the VN is a central link in the brain-gut axis and
contributes to the neural modulation of digestive (i.e., vagovagal) reflexes. The vagal afferents transmit glutamatergic
signals to the nucleus tractus solitarius (NTS) in response
to GI mechanical and chemical stimuli (Figure 1). Within
the caudal medulla, NTS interneurons may inhibit or excite
cholinergic vagal efferents of the dorsal motor nucleus of
the vagus (DMV). These DMV efferent neurons complete the
vago-vagal circuit (Browning and Travagli, 2010) by synapsing
onto parasympathetic postganglionic cholinergic or nonadrenergic non-cholinergic neurons in the submucosal and
myenteric plexuses of the ENS. The functional response
of the postganglionic enteric neurons may be excitatory
causing an increase in GI tone, motility, and secretion or
inhibitory preventing GI digestive functions (Travagli et al.,
2006; Browning and Travagli, 2011). Proper GI functioning
is dependent upon vagal reflexes, and any disruption in the
circuit leads to GI pathologies in the neurally intact including
but not limited to gastroparesis, dyspepsia, esophageal reflux,
colitis, anorexia and bulimia nervosa (Yamano et al., 1997;
Hornby and Abrahams, 2000; Andrews and Sanger, 2002;
Thumshirn, 2002; Saito et al., 2006; Ghia et al., 2007; Faris et
al., 2008).
Our research focuses on how CNS trauma modifies the GI

vago-vagal reflex and leads to GI dysfunction. Previously, we
have shown that gastric vagal efferents are intact following
experimental SCI, and DMV neurons projecting to the stomach
respond similarly to uninjured controls (Swartz and Holmes,
2014). Vagal afferents demonstrate a significant amount of
plasticity during both normal physiology and pathophysiology
such as high fat diet, diabetes, inflammation, and direct vagal
injury (Browning, 2003; Browning and Mendelowitz, 2003;
Li and Owyang, 2003; Raybould, 2010; Dockray and Burdyga,
2011; Kentish and Page, 2014; de Lartigue, 2016; Travagli
and Anselmi, 2016; Browning et al., 2017; Grabauskas and
Owyang, 2017; Cawthon and de La Serre, 2018; de Lartigue
and Xu, 2018). Therefore, we propose that vagal afferent
alterations may be, in part, responsible for GI dysfunction
following neurotrauma.
Gastrointestinal vagal afferent physiology
The GI vagal afferent cell bodies are contained within
the nodose ganglia (NG) and have both peripheral and
central projections (Figure 1). The vagal afferent terminal
nerve endings are diffusely spread throughout layers of
the walls of the proximal GI tract (reaching from mouth to
transverse colon in humans (Rea, 2014) and distal colon
in rats (Altschuler et al., 1993; Herrity et al., 2014). They
consist of mechanoreceptor morphological specializations,
known as intraganglionic laminar endings, for detecting
tension and stretch in the muscle wall and intramuscular
arrays which transduce stretch of the organ wall (Powley
and Phillips, 2002). Additionally, chemical stimuli such as gut
peptides like cholecystokinin (CCK) and ghrelin are detected
by chemoreceptors (Powley and Phillips, 2002) on vagal
afferent peripheral endings within GI mucosa or on the
vagal afferent somas within the NG. CCK and ghrelin elicit
opposite responses on the vagal afferents. CCK is released
from enterochromaffin I-cells when proteins and lipids are
taken into the GI tract. CCK then binds to CCK 1/A receptors
on the vagal afferents or NG, thus causing the vagal afferent
nerve firing to increase (Moran et al., 1990; Berthoud and
Patterson, 1996; Moriarty et al., 1997; Broberger et al., 2001;
Patterson et al., 2002). Ghrelin on the other hand, is released
from enterochromaffin X/A-cells during the fasting state.
Ghrelin acts on the growth-hormone secretgogue receptor
A on both the vagal afferents and NG to inhibit vagal afferent
firing (Kojima et al., 1999; Date et al., 2000, 2005; Page et al.,
2007). Other gut peptides act on and alter vagal afferent firing
such as: leptin, bombesin, PYY, secretin, GLP-1, serotonin, and
VIP. The actions of CCK, ghrelin, and these other gut peptides
have been thoroughly reviewed (Grabauskas and Owyang,
2017). The expression of the receptors of these gut peptides
have been shown to change based on the nutrient state of
the organism (Grabauskas and Owyang, 2017); demonstrating
plasticity under normal physiological conditions.
The fibers which carry the detected mechanical and
chemical stimuli can be classified into two primary groups:
lightly myelinated A-type and unmyelinated C-type afferent
fibers (Schild et al., 1994). A- and C-fibers have different
biophysical properties which have been thoroughly reviewed
(Browning, 2003). The types of fibers can be distinguished
by their myelination, firing rate, conduction velocity, and
action potential kinetics. A-fibers are lightly myelinated,
tonic firing neurons with a conduction velocity of 3–30 m/s
and unremarkable action potentials. While C-fibers are
unmyelinated, phasic firing neurons with a conduction
velocity of 0.8–1.2 m/s and distinguishing action potentials.
C-fibers make up 80–90% of the vagal afferents and have a
noticeable hump during the repolarization phase of their
action potential. A- and C- fibers are also distinguished by
their different ion channels which contribute to their action
potential. Of particular importance, IKCaS, ID, IA, IH, TTX-S and
TTX-R INa, and T- and L- type ICa currents give vagal afferent
fibers unique action potential features depending upon the
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Figure 1 ｜ Major vagal afferent innervation.
The majority of the vagus nerve is comprised of sensory fibers and the
cell bodies of vagal afferents are contained within the co-joined jugular
and nodose ganglia. The afferent vagus innervates from the oral cavity to
the transverse colon in humans, but tracing studies in rodent models have
demonstrated afferent projections as caudal as the rectum, bladder, and
reproductive tract. Vagal afferents carry mechanical and/or chemical sensory

information to the caudal medulla, specifically the NTS and nucleus ambiguus.
The cell bodies of the gastrointestinal viscera are distributed throughout the
nodose ganglia (depicted in red) and vagally-mediated reflexes dominate
esophageal and gastric reflexes. Functional alterations within all visceral
organs following pathophysiological remodeling may become more
pronounced in some disease and injury states. GI: Gastrointes tinal; NTS:
nucleus tractus solitarius.

ion channel expression (Schild et al., 1994).

neuroenteric axis; Bansal et al., 2010) disturbances are a
major cause of GI dysfunction post-TBI (Browning and Travagli,
2011; Kharrazian, 2015). Vago-vagal circuit disturbances
contribute to several GI dysfunctions (Browning and Travagli,
2011). Yet, the exact mechanisms of GI dysfunction following
TBI remain unclear. Several functional bowel disorders, which
lead to chronic GI disorders, are associated with long-term
dysregulation of the autonomic nervous system (Tougas,
2000). TBI commonly presents with neural deficits and
autonomic dysfunctions and is capable of causing chronic GI
disorders. However, the neural and autonomic dysregulation
is variable across studies but often results in decreased
GI motility among other GI complaints (Tougas, 2000).
Autonomic imbalances, or dysautonomia, are hypothesized
to occur when the sympathetic and parasympathetic divisions
of the ANS fail to properly integrate signals between the brain
and viscera (Baguley et al., 2008). Dysautonomia has been
reported in 8–33% of TBI individuals and is characterized by
chronic sympathetic over-activity (Kirk et al., 2012) which
may suggest parasympathetic dysfunction. ANS dysfunction
is evident following TBI (Esterov and Greenwald, 2017) and
persistent disruption of brain-visceral axes may be one culprit
of multi-organ dysfunction following TBI. However, we are
interested in the vagal afferent signaling following the axis
disturbances.

Beyond A- and C-fibers, vagal afferents can also be classified
by their neurochemistry. The neurochemistry of the vagal
afferent neurons of the NG includes the neurotransmitters
glutamate, catecholamines, serotonin, and acetylcholine, as
well as a considerable number of neuropeptides including
substance P, neurokinin A, vasoactive intestinal peptide,
calcitonin gene-related peptide, galanin, encephalin,
somatostatin, CCK, neuropeptide Y, calcium-binding proteins,
and other neuroactive molecules (i.e., nitric oxide; Zhuo et
al., 1997). Additionally, beyond the mechanical and chemical
stimuli, there is emerging evidence that vagal afferents
transmit nociceptive information (Surdenikova et al., 2012).
Transient receptor potential (TRP) channels have been
shown to be expressed in GI-projecting vagal afferents (Yu et
al., 2016). These fibers respond to acid, heat, cold, stretch,
capsaicin, menthol, inflammatory mediators, and other
stimuli which are associated with pain. Together under normal
conditions, these vagal afferents contribute to the precise
control and modulation of GI functions.

Altered Physiology of Gastrointestinal Vagal
Afferents Following Neurotrauma
Since the mid-nineteenth century, GI comorbidities have been
noted with CNS traumas (Cushing, 1932). These profound
changes to the GI system after CNS trauma suggest there
is VN involvement. In other pathophysiological states such
as high fat diet, diabetes, inflammation, and direct vagal
injury (Browning, 2003; Browning and Mendelowitz, 2003;
Li and Owyang, 2003; Raybould, 2010; Dockray and Burdyga,
2011; Kentish and Page, 2014; de Lartigue, 2016; Travagli
and Anselmi, 2016; Browning et al., 2017; Grabauskas and
Owyang, 2017; Cawthon and de La Serre, 2018; de Lartigue
and Xu, 2018), vagal afferents have been shown to be
extremely plastic. The combination of GI dysfunction and
vagal afferent plasticity in other pathophysiological models
suggests vagal afferent plasticity after CNS trauma, as well.
Therefore, this section focuses on the altered physiology of
vagal afferents following neurotrauma and identifies major
knowledge gaps within the field.
Traumatic brain injury
Vagal afferent plasticity following TBI is significantly
understudied, yet, it is known that brain-gut axis (or

The vago-vagal synaptic transmission is modulated by a variety
of signals including afferent inputs and neurohormones (such
as CCK; Browning and Travagli, 2011). Vagal afferent sensitivity
can decrease depending on specific receptor activation.
Particularly, CCK-A receptors have been found on vagal afferents
(Li, 2007) and electrophysiological activation of these receptors
alters the sensitivity of the fibers which then modulates
efferent output to the GI tract. Decreased sensitivity, from
activation of CCK-A receptors on vagal afferents, can directly
affect second messenger systems in NTS neurons and activate
GI-inhibitory efferent pathways in the circuit. This modulation
and subsequent GI-inhibition has been shown experimentally
with CCK (Browning and Travagli, 2011). In an animal model of
TBI, several GI pathologies were discovered including gastric
distension, intestinal dilation, and intestinal effusion suggesting
delayed gastric emptying and paralytic ileus. Additionally,
plasma and jejunum CCK levels were elevated in the post-TBI
rats potentially altering the GI vagal afferent responses (Forster
et al., 1990; Higham et al., 1997; Shoji et al., 1997; Hang et al.,
2004). Increased CCK levels following TBI may be one source
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of GI dysfunction through activation of the vago-vagal NTSinhibitory pathway from altered vagal afferent input.
Vagal afferent inputs to NTS neurons are further influenced
by tumor necrosis factor alpha (TNF-α; Travagli et al., 2006).
In a preclinical model, TNF-α has been shown to favor the
GI-inhibitory state by acting on the vago-vagal circuit (Emch
et al., 2000). Specifically, it has been shown to cause gastric
stasis (Hermann et al., 2005) through modulation of NTSDMV synaptic transmission. Experimental models have
revealed increased circulating TNF-α following TBI (Taupin
et al., 1993; Tchelingerian et al., 1993; Shohami et al., 1994;
Fan et al., 1996; Gourin and Shackford, 1997; Knoblach et al.,
1999; Schmidt et al., 2005), alters synaptic transmission by
selectively activating inhibitory or inhibiting excitatory NTS
neurons which then synapse with DMV neurons for efferent
outflow. The modulation occurs through changes in the glial
environment, specifically through astrocyte gene expression
changes which may cause long-term changes in the sensitivity
of the vago-vagal circuit. The glial-neuronal communication
may be responsible for leading to the activation of the GIinhibitory efferent output and potentially be a therapeutic
target. However, while TNF is elevated post-TBI, TNF has
displayed both neuroprotective and neurotoxic effects in
various models of CNS injury (Longhi et al., 2013).
Additional preclinical studies investigating the glial-neuronal
communication between astrocytes and NTS neurons
(Hermann et al., 2009; Vance et al., 2015) have also been
found to disrupt vago-vagal circuitry. In a rat model, Hermann
et al. (2009) showed a significant reduction in gastric transit
by using a protease-activated receptor agonist to mimic the
autonomic disruption first described by Cushing (1932) which
occurs following a bleeding head injury. In this study, the
interaction of thrombin with protease-activated receptors in
the dorsal vagal complex activated astrocytes which in turn
excited inhibitory-NTS neurons evoking inhibition of gastric
motility. It is important to note that the autonomic astrocytes
may play a role similar to that of neurons in the vago-vagal
circuitry. The glial-neural interactions are multi-directional and
visceral afferent inputs regulate astrocyte activity (McDougal
et al., 2011; Accorsi-Mendonça et al., 2013). Therefore,
alterations in vagal afferent input following TBI, may affect
more than the neuronal synapses in the vago-vagal circuit.
Modification of the vago-vagal reflex circuit following TBI,
remains a contributing factor of brain-gut axis disruption
(Kharrazian, 2015). These vago-vagal alterations are largely
involved in GI dysfunction and elicit greater research on the
vagal afferent changes post-TBI.
Lastly, in a mouse model of TBI, Bansal et al. (2009) showed
that following TBI, intestinal permeability increased while
protein expression of cell junction proteins decreased.
Furthermore, there was an increase in intestinal TNF-α and
other investigators have also reported increased expression
of inflammatory cytokines post-TBI (Hang et al., 2005a, b;
Katzenberger et al., 2015). While it is not clear whether the
inflammation leads to the increased intestinal permeability,
a preclinical study used a knockout mouse model equipped
against inflammation to support the hypothesis that specific
pro-inflammatory cytokines correlate with higher intestinal
permeability following TBI (Jin et al., 2008). Yet, the source of
intestinal inflammation post-TBI remains unclear. Alternatively,
the source of increased intestinal permeability has been
proposed as a heightened adrenergic state post-TBI, further
highlighting the significance of a healthy brain-gut axis in
proper gut functioning (Bansal et al., 2009).
The significance of diminished barrier integrity and heightened
inflammatory state is revealed in an animal study by Ammori
et al. (2008) that reported cellular degeneration in DMV vagal
efferent neurons following experimental colitis. The potential
for inflammatory cytokines to traverse the gut-brain axis (or

enteric-neuro axis) and negatively affect neuronal survival
provides another source of vago-vagal alteration (Bansal et
al., 2010). Furthermore, preclinical studies reveal significant
ENS changes caused by intestinal inflammation such as
neuronal loss (Sanovic et al., 1999), hyperexcitability (Linden
et al., 2003), and altered neurotransmitter release (Linden
et al., 2005) causing changes in sensory interoceptive input
and DMV structure (Ammori et al., 2008). Consistent with
the negative impact of intestinal inflammation on neuronal
populations of DMV and ENS neurons, DMV apoptosis is
reversed by the anti-inflammatory role of ghrelin in an animal
model (Qi et al., 2011). In addition to the cell loss, the time
course of neuronal damage and plasticity caused by intestinal
inflammation post-TBI is unknown.
Spinal cord injury
There is limited research investigating GI vagal function and
plasticity in human SCI individuals. Of the few clinical studies
examining SCI vagal function in general, one study utilized
functional magnetic resonance imaging to measure brain
activation from bladder fullness in complete SCI individuals
(Krhut et al., 2017). Krhut et al. (2017) found a subset of
subjects that had activation in nuclei (NTS and parabrachial
nucleus) associated with vagal afferent activity. Under
normal conditions these nuclei are not activated by bladder
fullness, and suggest following SCI, there is vagal afferent
plasticity or collateral sprouting occurring to re-innervate the
bladder. Studies investigating female genital sensation after
complete SCI also demonstrated new NTS activation, similarly
suggesting new vagal afferent plasticity after SCI (Whipple
and Komisaruk, 2002; Komisaruk et al., 2004). These studies
demonstrate vagal plasticity after SCI, and GI vagal afferent
dysfunction could be a promising avenue for further clinical
research.
Preclinical rodent models of SCI also exhibit GI dysfunction.
Our lab along with Gondim et al. have shown delayed gastric
emptying and decreased GI transit time in SCI rats (Gondim
et al., 1998; Tong and Holmes, 2009; Qualls-Creekmore et
al., 2010) indicating a disruption in the vago-vagal reflexes.
Gondim and colleagues’ studies were the first to observe
an upper thoracic (T1 or T5) spinal cord transection in rats
leads to delayed gastric emptying and delayed GI transit of
liquid (Gondim et al., 1998, 2001; Rodrigues et al., 2001). We
expanded these findings by demonstrating that upper thoracic
T3-SCI animals show a diminished food intake (Primeaux et
al., 2007), a significant reduction in gastric motility (Tong and
Holmes, 2009) that lasts as long as 6 weeks after injury, and
a delay in gastric emptying of a 13C-tagged solid meal (QuallsCreekmore et al., 2010). It has been hypothesized that GI
dysfunction is due to a vagally-mediated mechanism (Gondim
et al., 2001; Tong and Holmes, 2009; Holmes, 2012).
Our lab has further found that vagal efferents remain
anatomically and functionally intact after T3-SCI (Swartz
and Holmes, 2014) but are silent due to lack of presynaptic
stimuli (Tong et al., 2011). For example, NTS neurons are not
activated after central or peripheral administration of CCK8s in a T3-SCI model but respond to other depolarizing drugs,
such as 4-aminopyridine, suggesting that afferents within the
NTS are capable of releasing neurotransmitters but are not
stimulated by GI peptides (Tong et al., 2011). However, the
NTS receives afferent input from many brain regions, vagal
afferents, and spinal afferents; therefore, this study could not
conclude that the vagal afferents were altered specifically.
Our most recent study demonstrates directly that vagal
afferents are hyposensitive to stimuli, both chemical and
mechanical, after SCI (Besecker et al., 2020). We confirmed
hyposensitivity of vagal chemoreceptors to CCK-8s and
demonstrated novel mechanical hyposensitivity to von
Frey Hair stimuli, and interestingly, TRPV1 receptor agonist,
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capsaicin, showed hypersensitivity in vagal afferents after SCI.
These data suggest SCI provokes exceptional functional vagal
plasticity and impairs vagal afferent signaling necessary for
proper GI reflexes. Furthermore, another recent study of ours
has reported this hyposensitivity is not specific to CCK and
mechanical stimuli, but includes ghrelin (Besecker et al., 2018)
and may involve other GI peptides not yet tested (Besecker et
al., 2017).
A recent investigation in a chronic SCI rodent model, studied
vagal afferents as a whole (i.e., not organ specific; Herrity
et al., 2015). They demonstrated that SCI impacts the
neurochemical characteristics of vagal afferents, by increasing
P2X3 receptor expression and decreasing isolectin 4 binding
in whole NG (Herrity et al., 2014). This study demonstrated
SCI has the ability to change the phenotype of vagal afferents,
but specific changes within GI vagal afferents remain to be
determined.
Based upon these studies, we propose that SCI-induced
pathophysiological plasticity occurs within vagal afferents
and NG though the degree remains unknown. Multiple
mechanisms can be proposed to account for the loss-offunction in vagal afferents, such as altered trafficking of
receptors, receptor plasticity and/or adaptation, disruption
of intracellular signaling pathways, ionic imbalances,
degeneration of nerve endings, or loss of function of
gated ion channels. In the case of SCI, it is unknown what
electrophysiological phenotype is exhibited in vagal afferents
after injury. However, following SCI in rodent models, other
sensory afferents, such as the dorsal root ganglia, have shown
to have both decreased (Yoshimura and de Groat, 1997; Black
et al., 2003) and increased (Black et al., 2003; Yang et al.,
2014) expression and function of TTX-R NaV channels: thus,
resulting in hyperexcitability or hypoexcitability of sensory
afferents depending on the target organ they innervate
similar to what is seen in vagal afferents in our SCI model
(Besecker et al., 2020). Other voltage-gated channels, such
as KV3.4 (Ritter et al., 2015), in dorsal root ganglia have been
shown to be altered by SCI, as well. The SCI-induced changes
in electrophysiological properties of sensory afferents have
not been expanded to the vagal afferents, thus opening more
promising avenues for further research.

Gastrointestinal Microbiome
The GI microbiome plays a critical role in health and disease
(Kigerl et al., 2016; Sherwin et al., 2016; O’Connor et al.,
2018). The bidirectional pathway or the microbiota-gut-brain
axis (Rhee et al., 2009; Bercik, 2011; Cryan and O’Mahony,
2011; Cryan and Dinan, 2012; Burokas et al., 2015; Mayer et
al., 2015) is emerging as a critical communication line between
the GI microbiome and brain (Sherwin et al., 2018) via the VN,
immune mediators, microbial metabolites, and modulation
of circulating tryptophan (O’Mahony et al., 2015; Scott et al.,
2015; Foster et al., 2016; Sarkar et al., 2016; Sherwin et al.,
2016). GI microbes indirectly influence neural communication,
such as the vagal afferents, via the production of metabolites
(e.g., short-chain fatty acids), synthesis of neurotransmitters
(e.g., gamma-aminobutyric acid, noradrenaline, and
dopamine), and immune system modulation (Sherwin et
al., 2016). Disruptions in the microbiota-gut-brain axis of
the VN contribute to both GI (Mulak and Bonaz, 2004;
Bonaz and Bernstein, 2013; Oświęcimska et al., 2017) and
neurodegenerative disorders (Cenit et al., 2017; Kobayashi et
al., 2017; Quigley, 2017). Vagal afferents use gut endocrine
cell interactions (Raybould, 2010), direct and receptor
activation (Goehler et al., 1999; Lal et al., 2001), and CCKmediated mechanisms (Lal et al., 2001) to detect GI microbial
compounds or metabolites and carry the information to the
brain. The NG contributes to the brain-relay by responding
to bacterial products such as lipopolysaccharide (Hosoi et al.,

2005). Information along the vagal pathway reaches the brain
to elicit adaptations or inappropriate responses, the latter
contributes to GI and neurodegenerative pathophysiologies
(Eisenstein, 2016; Tse, 2017).
While several preclinical studies have shown vagal nerve
activity in response to GI microbes (Gaykema et al., 2004;
Tanida et al., 2005; Raybould, 2010; Bravo et al., 2011; PerezBurgos et al., 2013), clinical vagal afferent activation via GI
microbiota remains hypothetical (Bonaz et al., 2018). For
further review of GI microbiota and the microbiome-gut-brain
axis, please see (Burnet and Cowen, 2013; Wang and Kasper,
2014; Kelly et al., 2015; Moos et al., 2016). Additionally, a
preclinical model has shown evidence of gut microbiota
modulating satiety signals, specifically increasing GLP-1 and
PYY plasma levels, favoring anorexigenic signaling to the brain
(Breton et al., 2016); such GI microbiota influence on feeding
behaviors may be responsible for the GI dysfunction following
neurotrauma. Gaining a better understanding of the influence
altered gut microbes have on the brain following trauma, may
lead to interventions for reduced comorbidities and improved
functional outcomes. However, there are limited clinical
studies on the microbiome-gut-brain axis following TBI and SCI
(O’Connor et al., 2018).
Dysbiosis following traumatic brain injury
Dysbiosis is a result of pathogenic bacteria outnumbering
beneficial nonpathogenic gut bacteria resulting in undesired
health outcomes. GI dysbiosis occurs within 2 to 24 hours after
TBI (Treangen et al., 2018; Nicholson et al., 2019) and remains
altered in chronic TBI (Ma et al., 2017) in rodent models. In the
study by Treangen et al. (2018) the microbiota changes postTBI include decreased Ruminococcus flavieciens, increased
Eubacterium ventriosum, and increased Marvinbryantia
formatexigens. Thus, this study demonstrated a change in
Firmicutes/Bacteroidetes ratio and succinate-producing
microbes. Sherwin et al. (2018) noted that the surge in SNS
activation may be responsible for altering post-TBI microbiota
as observed in a study in mice (Houlden et al., 2016). This
work demonstrated a decrease in the intestinal microbiota
family Prevotellaceae post-TBI, while levels of norepinephrine
release and noradrenergic innervation in the cecum increased
in mice (Houlden et al., 2016). Additionally, norepinephrine
levels have been shown to increase, in both animal and human
studies, following trauma (Millen et al., 1985; Woolf et al.,
1992; Lyte and Bailey, 1997) exuding a sympathetic dominance
which may contribute to the GI dysfunction. However,
norepinephrine has recently been shown to reduce the relative
abundance of certain species of the genus Prevotella (from
the family Prevotellaceae) in vitro (Jentsch et al., 2013). Less
is understood about the family Peptococcaceae, but increases
(as demonstrated in mice (Houlden et al., 2016)) have been
correlated with increased expression of the proinflammatory
cytokine (CCL5) which has been linked to colitis development
(Elinav et al., 2011) in mice.
The work by Durham et al. (2016) as well as several other
studies (Rogers et al., 2016; Duvallet et al., 2017; Sun and
Shen, 2018; Winter et al., 2018) indicate the involvement of
the brain-gut axis in TBI-related neuropathologies which has
recently expanded to include TBI-GI pathologies suggesting
microbiome-gut-brain-axis (Mayer et al., 2015; Martin
and Mayer, 2017; Sundman et al., 2017) disruption. The
paradox remains in that GI microbial shifts alter VN activity
(microbiota-gut-brain axis) and GI dysfunction alters GI
microbial populations (brain-gut-microbiota axis). However,
evidence is beginning to indicate that probiotic treatments
may be capable of healing the injured brain by repairing postTBI gut dysbiosis (Treangen et al., 2018).
Dysbiosis following spinal cord injury
Reviews of the current SCI microbiome literature can be
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found in (Holmes and Blanke, 2019; Wallace et al., 2019) but
briefly, investigators have shown that gut dysbiosis occurs
following SCI. Similar to the TBI-microbiome preclinical study,
Kigerl et al. (2016) showed that the Firmicutes/Bacteroidetes
ratio also increased following SCI in mice. Additionally, in
another SCI rodent model, the following GI microbiota
changes were detected: increased Lactobacillus intestinalis,
Clostridium disporicum, and Bifidobacterium choerinum while
relative abundance of Clostridium saccharogumia decreased
(O’Connor et al., 2018). High prevalence of Lactobacillaceae
family has been correlated with carbohydrate fermentation to
lactic acid, and Kigerl et al. (2016) revealed post-SCI functional
recovery correlations to lactic acid supplementation.
Clostridium spp. have been found to be both helpful and
harmful but the functional implications of C. disporicum
remain to be further understood. In humans, the family of
Bifidobacteriaceae is probiotic and found in healthy guts
conferring positive health benefits (O’Callaghan et al., 2015).
Lastly, while literature reveals deleterious effects on the host
when C. saccharogumia is depleted, the significance of this
is low with the increased relative abundance of the other
commensal microbes (O’Connor et al., 2018).
These microbiota changes were inversely correlated
with intestinal inflammatory changes. The intestinal
proinflammatory cytokines likely suppressed microbial taxa
responsible for butyrate production in the GI tract. Butyrate
plays a critical role in gut health through its anti-inflammatory
properties by supporting intestinal cell cycles, its pathogenprotection activities, modulation of the immune system,
and reduction of cancer progression (Gungor et al., 2016;
O’Connor et al., 2018). Previous preclinical studies analyzed
the effects of Faecalibacterium prausnitzii, a known butyrateproducing microbe, and found it to have protective effects
on the gut (Miquel et al., 2013). O’Connor et al. (2018) noted
F. prausnitzii to be depleted in SCI mice with significantly
increased levels of proinflammatory cytokines (Miquel et
al., 2013; Kigerl et al., 2016). Similarly, a decrease in the
abundance of butyrate-producing bacteria correlates with gut
dysbiosis in clinical SCI (Ferrante et al., 2003; Sun et al., 2015;
Butchbach et al., 2016; Gungor et al., 2016; Li et al., 2016).
As observed with the TBI-microbiota changes, the microbial
shift post-SCI is towards a recovery profile to the host; yet
many health-related microbes are depleted due to the chronic
inflammatory state of the GI tract post-neurotrauma.
While much remains to be understood with microbiota effects
on system physiology, characterizing GI microbiota is critical
following neurotrauma. The characterization, identification of
physiological roles, and determination of critical time-points
of the changing microbiota will help in designing therapeutic
interventions for TBI- and SCI-related GI comorbidities.

Conclusion
Neurotrauma causes profound changes to ANS control of the
GI system. GI dysfunction contributes to increased morbidity
and mortality. However, neural plasticity offers the ability to
target specific mechanisms and treat GI dysfunctions following
CNS injury, but the exact mechanisms of disruption remain
largely under-researched. Following TBI, the GI vagal afferents
exhibit modified receptor-, peptide-, and glial-interactions
which favor the inhibitory-NTS vagal efferent pathway. Vagal
efferent and ENS neuronal populations decrease following
intestinal inflammatory insult, and may be an on-going cycle
across synapses in the vago-vagal reflex circuit. These vagal
afferent and efferent interactions and reactions may serve as
suitable therapeutic targets in repairing GI dysfunction postTBI, but the exact mechanisms which contribute to these
changes and the system-wide interactions from such plasticity
need to be better understood.
The effects of SCI on GI dysfunction still remains a significant

knowledge gap. From the above studies, we know human
vagal afferents show significant re-wiring post-SCI to activate
once-quiet NTS neurons. This modified afferent input
following SCI remains unclear but shows potential for reactivation of vago-vagal reflexes. In animal models of SCI, it
has been shown that GI vago-vagal reflexes are disrupted.
While the vagal efferents remain intact, they fail to respond
spontaneously due to lack of presynaptic stimuli. This further
suggests vagal afferent alterations. Furthermore, we have
reported that GI vagal afferents are hyposensitive to chemical
and mechanical stimuli but selectively hypersensitive to
noxious chemical stimuli. Lastly, SCI changes phenotypic
profiles of NG by increasing P2X3 receptor expression and
decreasing isolectin 4 binding. While little is known about
the plasticity of GI-vagal afferents following SCI, the research
suggests that vago-vagal reflexes are affected and responsive
to changing conditions. Upon further understanding of the
mechanisms of plasticity in the vago-vagal circuit, we will
strengthen the efforts of finding treatments for GI pathologies
following neurotrauma.
There is an emerging discussion that neurotrauma is a
systemic pathology (Figure 2). The vago-vagal reflex circuit
is anatomically intact after TBI and SCI, suggesting the
derangements to the GI vago-vagal reflexes must be due to a
secondary cascade of events. The components of the vagovagal reflex are optimally poised to sense secondary events
such as systemic inflammation. Immediately following trauma
to the CNS, regardless of location, a systemic inflammatory
response (SIR) ensues (Anthony and Couch, 2014; Schwab
et al., 2014; Sun et al., 2016). SIR following SCI has been
thoroughly reviewed (Sun et al., 2016; Bloom et al., 2020).
For SCI, the SIR is characterized by increased levels of
circulating inflammatory mediators and cells, activation of
resident glial and immune cells, and infiltration of neutrophils,
macrophages and lymphocytes, all of which culminate in
multiple organ failure (Sun et al., 2016; Bloom et al., 2020).
The SCI-induced SIR is triggered within hours and persists
for weeks following injury, and currently there is no clinical
evidence to support the use of any neuroprotective drugs
to improve functional outcomes after SCI (Popovich et al.,
2001; Campbell et al., 2005; Gris et al., 2008; Wing, 2008;
Sauerbeck et al., 2015; Bloom et al., 2020). Studies of other
inflammatory disease models have examined the effects
of systemic inflammation on vagal afferents and have been
reviewed (Browning et al., 2017). Briefly, inflammation has
shown to decrease vagal afferent response to leptin and CCK,
while increasing mechanosensitivity, TRP and P2X receptors
and NaV channel expression (Browning et al., 2017). Our
preclinical SCI reports of decreased GI vagal afferent response
to CCK (Tong et al., 2011; Besecker et al., 2020), increased
TRPV1 expression and hypersensitivity (Besecker et al., 2019),
along with the preclinical report by Herrity et al. (2015) of
increased P2X3 receptor expression in NG after SCI, insinuate
a similar mechanism. This suggests systemic inflammation
may cause pathophysiological plasticity within vagal afferents
after SCI (Figure 2). Lastly, inflammation has been shown to
alter the GI microbiota preclinically (O’Connor et al., 2018).
The inflammatory profile causes dysbiosis causing disruption
to the microbiota-gut-brain axis. This disruption may be
the culprit of the chronic GI and neurological disorders
seen in neurotrauma individuals. By understanding the GI
microbiome, and developing a healthy gut profile, we may be
equipped with probiotics necessary to reverse the long-term
GI and neural deficits in TBI- and SCI individuals.
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Figure 2 ｜ Vagal afferent plasticity following neurotrauma.
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This dysregulation may exist in concert with, or independent of, alterations in
the gut microbiome. F/B: Firmicutes/Bacteroidetes ratio; GI: gastrointestinal.
NTS: Nucleus tractus solitarius; SCI: spinal cord injury; TBI: traumatic brain
injury.
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